Not finding it? Sign in to also search OpenAlex live.
-
Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia
Johannes Schetelig, Henning Baldauf, Linda Köster, Michelle Kuxhausen, Falk Heidenreich, Liesbeth C. de Wreede, +16 more
25citations -
Allogeneic Hematopoietic Cell Transplantation in Patients ≤ 60 Years with Intermediate-Risk Acute Myeloid Leukemia in First Remission - Results of the Randomized Etal-1 Trial-
Martin Bornhaeuser, Christoph Schliemann, Johannes Schetelig, Christoph Röllig, Michael Krämer, Bertram Glaß, +21 more
2citations -
Microvesicle-Mediated Tissue Regeneration Mitigates the Effects of Cellular Ageing2023 Cells article Biochemistry, Genetics and Molecular Biology Extracellular vesicles in disease Open access
Dagmara McGuinness, Armand M. G. Jaminon, Barend M.E. Mees, Colin Selman, Leon J. Schurgers, Paul G. Shiels
1citations -
Microvesicle-Mediated Tissue Regeneration Mitigates the Effects of Cellular Ageing2022 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology Extracellular vesicles in disease Open access
Dagmara McGuiness, Armand M. G. Jaminon, Barend M.E. Mees, Colin Selman, Leon J. Schurgers, Paul G. Shiels
0citations -
Comparative Study of Unrelated and Haploidentical Donor Hematopoietic Cell Transplant for Chronic Myeloid Leukemia with Post Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis: A Study from the Chronic Malignancies Working Party of EBMT
Guillermo Ortí, Luuk A. Gras, Nienke Zinger, Alexander Kulagin, Jenny Byrne, Jane F. Apperley, +18 more
0citations -
Conditioning Intensity in Patients Aged > 50 Years Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrom: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT
Noureddine Loukili, Luuk A. Gras, Linda Köster, Didier Blaise, Tobias Gedde‐Dahl, Johan A. Maertens, +19 more
0citations -
Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study2021 Haematologica article Medicine Hematopoietic Stem Cell Transplantation Open access cited by 1 patent
Hildegard T. Greinix, Dirk‐Jan Eikema, Linda Köster, Olaf Penack, Ibrahim Yakoub‐Agha, Silvia Montoto, +15 more
85citations -
Post-Transplant Cyclophosphamide for Graft Vs Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison By Donor Type; A Study from the Chronic Malignancies Working Party of the EBMT
Firoozeh Sahebi, Dirk‐Jan Eikema, Linda Köster, Nicolaus Martin Kröger, Ellen Meijer, Goda Choi, +19 more
1citations -
Transplantation for Congenital Sideroblastic Anaemia Is Feasible and Offers Outcomes Comparable to Other Transfusion Dependent Anaemias. a Joint Retrospective Study of the Paediatric Diseases and Severe Aplastic Anaemia Working Parties (PDWP/SAAWP) of EBMT
Josu de la Fuente, Dirk‐Jan Eikema, Paul V. Bosman, Robert Wynn, Miguel Ángel Díaz, Peter John Shaw, +24 more
1citations -
Decreased Chronic GvHD With Post‐Transplant Cyclophosphamide Versus ATG in Patients With Myelofibrosis Allografted With an Unrelated Donor: A Study From the Chronic Malignancies Working Party of the EBMT2026 American Journal of Hematology article Medicine Hematopoietic Stem Cell Transplantation Open access
Yves Chalandon, Edouard F. Bonneville, Diderik-Jan Eikema, Liesbeth C. de Wreede, Linda Köster, Joe Tuffnell, +24 more
1citations -
Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm Following Treatment for Lymphoma: A Study of the Chronic Malignancies Working Party of the EBMT
Mitja Nabergoj, Dirk‐Jan Eikema, Nienke Zinger, Uwe Platzbecker, Katja Sockel, Jürgen Finke, +19 more
0citations -
Impact of Specific Adverse Cytogenetic Features on Outcomes after Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome with Very Poor Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of EBMT
Xavier Poiré, Diderik-jan Eikeman, Linda Köster, Johan A. Maertens, Jan J. Cornelissen, Nathalie Fegueux, +18 more
0citations -
Interindividual HLA Evolutionary Divergence in Single HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation for Malignant Hematological Disorders: A Report on Behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT
Simona Pagliuca, Jarl Mooyaart, Nicolaus Kröger, Jürgen Finke, Victoria T. Potter, Peter Dreger, +22 more
0citations -
Extracorporeal Membrane Oxygenation in Children with Coronavirus Disease 2019: Preliminary Report from the Collaborative European Chapter of the Extracorporeal Life Support Organization Prospective Survey
Matteo Di Nardo, Aparna U. Hoskote, Tim Thiruchelvam, Jon Lillie, Marie Horan, Sylvia Belda Hofheinz, +8 more
40citations -
Revesz syndrome revisited2020 Orphanet Journal of Rare Diseases article Biochemistry, Genetics and Molecular Biology Blood disorders and treatments Open access
Michael Karremann, Eva Neumaier‐Probst, Frank C. Schlichtenbrede, Fabian Beier, Tim H. Brümmendorf, Friedrich W. Cremer, +2 more
29citations -
Outcome of adult B-precursor acute lymphoblastic leukemia (ALL) treated with blinatumomab in addition to chemotherapy independent of MRD: First results from the national GMALL registry
Nicola Gökbuget, Matthias Stelljes, Walter Fiedler, Jens Panse, Andreas Viardot, Lisa Heberling, +14 more
1citations -
The Dutch Childhood Cancer Survivor Study (DCCSS)-LATER 2 kidney analysis examined long-term glomerular dysfunction in childhood cancer survivors
Esmee C.M. Kooijmans, Helena J. H. van der Pal, Saskia M. F. Pluijm, Margriet van der Heiden‐van der Loo, Leontien C.M. Kremer, Dorine Bresters, +11 more
26citations